This assay is useful for evaluating patients suspected with Chronic Autoimmune Hepatitis (CAH) or Primary Biliary Cirrhosis (PBC). Positive results for ASMA are consistent with the diagnosis of CAH. Presence of LKM antibodies with or without ASMA is consistent with Autoimmune hepatitis Type 2. Presence of AMA is consistent with PBC.